Loading data for RMTI — first visit, this takes a few seconds.

Rockwell Medical, Inc.

NasdaqCM: RMTI · Real-Time Price · USD
8.05
-0.02 (-0.25%)
At close: Sep 03, 2026, 8:00 PM
7.99
+0.00%
After-hours: 7:30 PM

The price, the headline numbers and the latest news, in one place.

Rockwell Medical, Inc. (RMTI) Stock Price, Analysis & Data

No data available

Bid5.69
Market Cap32.2M
Revenue (ttm)69.4M
Net Income (ttm)-5.24M
1.62
-1.3
n/a
114.07
P/B (ttm)0.90
P/S (ttm)0.46
Earnings DateNov 11, 2026
Ask10.11
Volume3,887
Avg. Volume (20D)34,860
Open7.85
Previous Close8.07
Day's Range7.85 - 8.05
52-Week Range4.89 - 18.50
Analystn/a
Price Targetn/a
Dividendsn/a
Ex-Dividend Daten/a

About RMTI

Rockwell Medical, Inc., together with its subsidiaries, engages in the development, manufacture, commercialization, and distribution of various hemodialysis products for dialysis providers worldwide. It offers citrapure citric acid concentrate, dri-sate dry acid concentrate, renalpure liquid acid concentrate, dri-sate acid concentrate mixer, renalpure acid concentrate, renalpure bicarbonate concentrate, sterilyte bicarbonate concentrate, bicarbon...

Sector Healthcare
IPO Date Jan 27, 1998
Employees 157
Stock Exchange NasdaqCM
Ticker Symbol RMTI
Full Company Profile

Financial Performance

In 2025, Rockwell Medical's revenue was 69.26M, a decrease of -31.76% compared to the previous year's 101.49M. Earnings were -5.31M, an increase of 1,007.08%.

Financial Statements

Earnings Surprise

Rockwell Medical has released their quarterly earnings on Aug 13, 2026:
  • Revenue of $17.34M misses estimates by $0, with -8.34% YoY decline.
  • EPS of -0.34 misses estimates by -0.11, with 32.00% YoY growth.
Rockwell Medical, Inc. is scheduled to release its earnings on Nov 11, 2026, before market opens.
Analysts project revenue of ... Upgrade